| Literature DB >> 29391939 |
Yu Zhao1, Po-Yen Liu1, Kan-Yen Hsieh1, Pei-Ling Hsu1, Masuo Goto1, Susan L Morris-Natschke1, Horng-Jyh Harn2, Kuo-Hsiung Lee1,3.
Abstract
Z-K8 (2), the racemic form of isochaihulactone (1), previously showed significant antitumor effects in A549 and LNCaP tumor-bearing mice. In the present study, 17 derivatives of 2, were designed, synthesized and evaluated for anti-proliferative activity against four human tumor cell lines. All new derivatives exhibited high potency against A549 and P-glycoprotein (P-gp)-overexpressing KBvin. One of our new derivative exhibited greater activity against three tested tumor cells (A549, KB, and KB-VIN) than 2, and induced cell cycle arrest in the G2/M phase. Moreover, SAR conclusions were first established for this series of compounds. Our study clearly identified a structural feature that should be retained for good activity and also a moiety that can tolerate various modifications and, thus, is ideal for further changes.Entities:
Year: 2017 PMID: 29391939 PMCID: PMC5788313 DOI: 10.1039/C7MD00310B
Source DB: PubMed Journal: Medchemcomm ISSN: 2040-2503 Impact factor: 3.597